Authors
Loading...
Stage and M/V index may refine ovarian carcinoma prognosis; leaves open prospective validation before clinical adoption.
Key points are not available for this paper at this time.
Haapasalo et al. (1989) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: